Gene therapy for weight loss is being explored as a potential game-changer, with therapy aiming to program the body to produce its own GLP-1 hormone naturally.
New research reveals these medications impact everything from heart health to restaurant menus.
MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...
The research has generated significant interest from firms in food & supplements as consumers seek natural alternatives to ...
By reinforcing exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and ...
Diabetes care is undergoing a major transformation driven by GLP-1 receptor agonists, which have expanded beyond glycemic ...
Series D1 financing with participation from a syndicate of global healthcare-focused investors, including RTW Investments, SR One Capital ...
The KaiNETIC global Phase 3 clinical program includes three global, double-blind, randomized, placebo-controlled Phase 3 trials (KaiNETIC-1, KaiNETIC-2, and KaiNETIC-3) to evaluate weekly ribupatide ...
A new study reveals stopping GLP-1 weight loss drugs leads to rapid weight regain, nearly four times faster than quitting ...
New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...
The Canadian Press on MSN
What is 'food noise' and why are we hearing about it amid the rise of GLP-1 meds?
TORONTO — Before Brenda Rogers started taking Ozempic in the spring of 2023, she didn't realize how much "food noise" was sapping her mental energy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results